K

KannaLife Sciences, Inc.

6 employees

Kannalife is a biopharmaceutical company that focuses on innovation in research and development of novel cannabinoid therapeutic agents.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Chemotherapy Induced Peripheral Neuropathy
Biotechnology
Chronic Traumatic Encephalopathy
KLS-13019
Hepatic Encephalopathy
Phyto-Medical
Cannabidiol
Pharmaceutical
US Patent #9611213
Cannabinoids
Health Care
CTE
CIPN
HE
US Patent #6630507
Pharmaceuticals

Date founded

2010

Funding rounds raised

Total raised

$3M

from 2 investors over 2 rounds

K

KannaLife Sciences, Inc. raised $3M on September 28, 2021

Investors: National Institute of Neurological Disorders and Stroke (NINDS)

K

KannaLife Sciences, Inc. raised $1.5M on March 7, 2013

Investors: Medical Marijuana, Inc.

FAQ